Brian Murphy

Brian Murphy is the current CEO at Nanovibronix. Prior to this, they were the Director of National Accounts for Wound Care Management at Mimedx Group, Inc from July 2012 to October 2016. At Mimedx, Brian was responsible for innovations in regenerative biomaterials. Brian oversaw the development of HydroFix and CollaFix, two device technologies, as well as AmnioFix and EpiFix, two tissue technologies. These technologies are processed from human amniotic membrane and utilize Mimedx's proprietary Purion Process. This process was developed by Surgical Biologics, a wholly-owned subsidiary of Mimedx, in order to produce a safe and effective implant for homologous use. To date, Surgical Biologics has supplied over 90,000 implants to distributors and OEMs for use in various sectors of healthcare, such as ophthalmology, orthopedics, spine care, wound care, and dentistry.

Brian Murphy has a Bachelor of Science in Communications from Southern Illinois University, Carbondale.

Some individuals on their team include Harold Jacob - Chief Medical Officer and Director, James Cardwell - Chief Financial Officer, and Itai Levinson - General Manager & Vice President, International Sales and Global Marketing.